BTG3 and systemic sclerosis: SSc-PH group 2 and SSc-ILD-PH patients had low DLco and high FVC/DLco ratio, were more frequently dcSSc, had shorter disease duration, more frequent nucleolar ANA and anti-Scl antibody.